DETAILED PRODUCT SEARCH

PRODUCT NAME

PRODUCT TYPE

FORM

PRODUCT ACTIVE INGREDIENT

COMMERCIAL SHAPE

SORT

Our Products

Mixagin

FormPowder for the concentrate for 50mg and 100mg solution for infusion

ACTIVE INGREDIENTMicafungin

COMMERCIAL SHAPE1 vial /box

Indicated for the treatment of invasive candidiasis in pediatric patients (including neonates) and adult patients, for the treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate, for the prophylaxis of Aspergillus and Candida infections in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT), or in patients expected to have neutropenia (absolute neutrophil count [ANC] < 500 cells/µL) for 10 days or longer, for use alone where other systemic antifungal treatment is not appropriate or tolerated, or in combination with another systemic antifungal treatment, in rescue treatment, or in the treatment of invasive aspergillosis.

EUGMP
BBS